JPMorgan Chase & Co’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
8,452
+7,344
| +663% | +$141K | ﹤0.01% | 4561 |
|
|
2025
Q1 | $12.3K | Buy |
1,108
+731
| +194% | +$8.09K | ﹤0.01% | 5390 |
|
|
2024
Q4 | $6.29K | Sell |
377
-683
| -64% | -$11.4K | ﹤0.01% | 5430 |
|
|
2024
Q3 | $10.8K | Sell |
1,060
-203,851
| -99% | -$2.07M | ﹤0.01% | 5311 |
|
|
2024
Q2 | $11.8M | Sell |
204,911
-2,736
| -1% | -$158K | ﹤0.01% | 1994 |
|
|
2024
Q1 | $6.91M | Sell |
207,647
-123,100
| -37% | -$4.1M | ﹤0.01% | 2359 |
|
|
2023
Q4 | $26.8M | Sell |
330,747
-9,614
| -3% | -$780K | ﹤0.01% | 1434 |
|
|
2023
Q3 | $55.5M | Buy |
340,361
+16,378
| +5% | +$2.67M | 0.01% | 970 |
|
|
2023
Q2 | $106M | Sell |
323,983
-5,285
| -2% | -$1.73M | 0.01% | 753 |
|
|
2023
Q1 | $90.9M | Buy |
329,268
+28,171
| +9% | +$7.78M | 0.01% | 764 |
|
|
2022
Q4 | $117M | Sell |
301,097
-35,233
| -10% | -$13.6M | 0.02% | 663 |
|
|
2022
Q3 | $80.4M | Sell |
336,330
-9,765
| -3% | -$2.33M | 0.01% | 756 |
|
|
2022
Q2 | $77.1M | Buy |
346,095
+142,680
| +70% | +$31.8M | 0.01% | 801 |
|
|
2022
Q1 | $139M | Buy |
203,415
+6,959
| +4% | +$4.74M | 0.02% | 661 |
|
|
2021
Q4 | $136M | Buy |
196,456
+7,082
| +4% | +$4.9M | 0.02% | 685 |
|
|
2021
Q3 | $140M | Buy |
189,374
+45,866
| +32% | +$34M | 0.02% | 668 |
|
|
2021
Q2 | $108M | Buy |
143,508
+87,125
| +155% | +$65.3M | 0.01% | 809 |
|
|
2021
Q1 | $46M | Buy |
56,383
+501
| +0.9% | +$409K | 0.01% | 1103 |
|
|
2020
Q4 | $47.6M | Buy |
55,882
+33,740
| +152% | +$28.8M | 0.01% | 995 |
|
|
2020
Q3 | $16.5M | Buy |
+22,142
| New | +$16.5M | ﹤0.01% | 1431 |
|